GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $86,000 | +138.9% | 28,155 | +55.1% | 0.01% | +140.0% |
| Q1 2020 | $36,000 | -30.8% | 18,155 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $52,000 | -22.4% | 18,155 | 0.0% | 0.01% | -33.3% |
| Q3 2019 | $67,000 | 0.0% | 18,155 | +12.9% | 0.01% | -10.0% |
| Q2 2019 | $67,000 | -18.3% | 16,080 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $82,000 | +127.8% | 16,080 | +52.7% | 0.01% | +100.0% |
| Q4 2018 | $36,000 | -40.0% | 10,530 | +5.0% | 0.01% | -46.2% |
| Q3 2018 | $60,000 | +114.3% | 10,030 | +47.9% | 0.01% | +62.5% |
| Q1 2018 | $28,000 | -17.6% | 6,780 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $34,000 | +240.0% | 6,780 | +69.5% | 0.01% | +125.0% |
| Q3 2017 | $10,000 | -56.5% | 4,000 | 0.0% | 0.00% | -63.6% |
| Q2 2017 | $23,000 | +155.6% | 4,000 | 0.0% | 0.01% | +83.3% |
| Q1 2017 | $9,000 | +350.0% | 4,000 | +100.0% | 0.01% | +200.0% |
| Q4 2016 | $2,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $565,000 | 0.18% |
| D.A. DAVIDSON & CO. | 851,101 | $2,604,000 | 0.05% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 17,090 | $52,000 | 0.02% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $37,000 | 0.02% |
| IHT Wealth Management, LLC | 28,155 | $86,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,012,430 | $3,098,000 | 0.01% |
| Ameritas Investment Company, LLC | 10,782 | $33,000 | 0.01% |
| Vivaldi Capital Management LP | 15,439 | $40,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $48,000 | 0.01% |
| Geneos Wealth Management Inc. | 37,017 | $108,000 | 0.01% |